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ABSTRACT 
Background: To explore possible markers of developmental immunotoxicity, we prospectively 
examined 56 children to determine associations between exposures to mercury and persistent 
organic pollutants since birth and the comprehensive differential counts of white blood cells 
(WBC) at age 5 years.   
Materials and methods: Extended differential count included: neutrophils, eosinophils, basophils, 
lymphocytes (including T cells, NK cells, and B cells), and monocytes. Organochlorine 
compounds (OCs) including polychlorinated biphenyls (PCBs) and pesticides, five 
perfluoroalkyl substances (PFASs), and mercury (Hg) were measured in maternal (n=56) and 
children’s blood at 18 months (n=42) and 5 years (n=56). We constructed latent functions for 
exposures at three different ages using factor analyses and applied structural equations models 
adjusted for covariates.  
Results: Prenatal mercury exposure was associated with depleted total WBC, especially for 
lymphocytes, where a one standard deviation (SD) increase in the exposure was associated with 
a decrease by 23% SD (95% CI: -43, -4) in the cell count. Prenatal exposure to OCs was 
marginally associated with decreases in neutrophil counts. In contrast, the 5-year PFASs 
concentrations were associated with higher basophil counts (B= 46% SD, 95% CI: 13, 79). 
Significantly reduced subpopulations of lymphocytes such as B cells, CD4-positive T helper 
cells and CD4 positive recent thymic emigrants may suggest cellular immunity effects and 
dysregulation of T-cell mediated immunity. 
Conclusion: Thus prenatal exposure to mercury and PFASs appears to have differential impacts 
on WBC counts.  
Keywords:  
Developmental exposure delayed effects 
Immunotoxicity  
Mercury  
Perfluoroalkyl substances  
Polychlorinated biphenyls  
White blood cell count 
  
1. Introduction 
Exposure to environmental pollutants may significantly affect the immune system and cause 
immunologic suppression in children [1]. The developing immune system appears to be highly 
sensitive to toxic effects, and experimental animal studies and in vitro assays have shown 
immunomodulatory effects of persistent organic pollutants (POPs), especially polychlorinated 
biphenyls (PCBs) [2-5], organochlorine pesticides (OCPs) [5-7], and perfluoroalkyl substances 
(PFASs) [8-10], as well as mercury and other metal compounds [11, 12]. These immunotoxicants 
are ubiquitous, most are persistent, and they are widely detected in children and adults from the 
general population [13].  
In humans, recent epidemiologic studies have reported immunomodulatory effects of 
mercury [14-16] and POPs [13, 17, 18] in children and adults. For example, higher exposures to 
PFASs were associated with a reduction of the humoral immune response to booster vaccination 
[17-19], whereas mercury exposures were associated with increased pro-inflammatory cytokines, 
antinuclear and antinucleolar autoantibodies and decreased anti-inflammatory cytokines [20]. 
Developmental exposure to PCBs and OCPs has also been shown to modulate the immune 
system in infants [21, 22], children [23], and adults [13]. Higher 6-month infant concentrations 
of PCB-153 and DDE [1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene] were strongly associated 
with lower 6-month BCG-specific antibody levels [24], and higher maternal and infant PCB 
concentrations have been associated with a reduced volume of the infant thymus, the site of T-
cell maturation [25]. Moreover, early-life environmental PCB exposure was associated with 
fluctuations in major lymphocyte subsets [26], and affected the dynamics of cell surface 
lymphocyte receptor expression [27]. Overall, previous studies provide compelling evidence of 
the detrimental effects of exposure to environmental toxicants on the immune system, 
including  immune cell counts, cytokine responses, and levels of specific antibodies [28]; 
However, most of the human studies on immunotoxicity of POPs and mercury lack a prospective 
design with age-related exposure profiles, and no study has so far attempted to examine the 
potential joint effect of different POPs on the immune system development. Hence, the need for 
new statistical tools to detangle the role of multiple exposures on multiple immune system 
markers [29].  
The white blood cell (WBC) count has been proposed as an immunologic end point to 
detect immunotoxic effects of environmental contaminants in prospective epidemiologic studies 
[30]. In humans, WBC counts have proven useful in signaling clinically relevant hematologic 
changes that may result in clinically identifiable immune disorders [31], with absolute numbers 
of WBC providing biologically more reliable information than percentages [32].  
In the present study, we explored the associations between exposures to POPs and 
mercury measured at birth and at ages 18 months and 5 years in regard to extended WBC 
differential counts at age 5.  
 
2. Materials and methods  
2.1. Study population 
The present study focuses on fifty-six children from a cohort of consecutive births formed in the 
Faroe Islands to include 490 children during an 18-month period between late 2007 and early 
2009. Whole blood was taken from the cord and from the mother two weeks after parturition. In 
addition, maternal hair at parturition was also sampled. Blood and hair were obtained from the 
child at successive clinical examinations at ages 18 months and 5 years. At age 5 years, children 
underwent detailed examinations including immune system biomarkers. On dates when fresh 
blood samples could be transported to the immunological laboratory in Denmark, we obtained 
maternal consent for a subgroup of 56 children to draw additional blood for the purposes of the 
present study. Standard questionnaires were used to record past medical history, current health, 
social factors, and nutritional habits during and before pregnancy. Relevant obstetric 
information, including birth weight, parity and maternal age were abstracted from hospital’s 
medical records. 
The study protocol was approved by the ethical review committee serving the Faroe 
Islands and by the institutional review board at the Harvard T.H. Chan School of Public Health, 
and written informed consent was obtained from all mothers. 
2.2. WBC counts and lymphocyte subsets 
The total number of WBCs, neutrophils, eosinophils, lymphocytes, and monocytes were 
recorded by standard procedures using the ABX Pentra DX 120 (Horiba, United 
Kingdom/Germany). Furthermore,  T-cell (CD3), T-helper cells (CD4), T-cytotoxic cells (CD8), 
B-lymphocytes (CD19), NK (CD16/56) cells and CD4+ recent thymic emigrants (CD4-RTE) 
absolute counts were performed by a single-platform no-lyse-no-wash procedure. Fifty µl EDTA 
anti-coagulated peripheral blood were incubated in TRUCount tubes (BD Biosciences, Denmark) 
with a panel of conjugated monoclonal antibodies. The following combinations of antibodies 
were used to characterize T cells as CD4 T cells (CD3-PerCP (clone SK7), CD4-FITC (clone 
SK3), CD8 T cells (CD3-PerCP (clone SK7), CD8-PE (clone SK1)) and CD4-RTE (recent 
thymic immigrant) cells as (CD3-ECD (clone UCHT1), CD4-PC7 (clone SFCT12T4D11), 
CD31-PE (clone WM59), CD45RA-FITC (clone L48), and CD45RO-PC5 (clone UCHL1), NK 
cells as (CD45-PerCP (clone 2D1), CD16/56-PE (clone B73.1 + NCAM16.2), and CD3-FITC 
(clone SK7)), and B cells as (CD19-PE (clone 4G7), CD45-PerCP (clone 2D1)) (BD 
Biosciences, Beckman Coulter and AbD Serotec, Denmark). The samples were measured on 
FC500 flow cytometer (Beckman Coulter, Denmark). The laboratory participates in the quality 
assurance program by National External Quality Assessment Site (NEQAS). 
2.3. Exposure assessment 
PCBs, OCPs (dichlorodiphenyltrichloroethane [DDT], dichlorodiphenyldichloroethylene [DDE], 
and hexachlorobenzene [HCB]) and PFAS (perfluorohexane sulfonic acid [PFHxS], 
perfluorooctanoic acid [PFOA], perfluorooctane sulfonate [PFOS], perfluorononanoic acid 
[PFNA], and perfluorodecanoic acid [PFDA]) were measured in cord (n=56), maternal (n=56) 
and children’s blood at 18 months (n=42) and 5 years (n=56). In addition, mercury (Hg) was 
measured in cord blood, maternal blood and hair, and in child blood and hair at 5 years.   
Serum analyses of DDE, DDT, HCB, and PCBs were carried out by the same procedure 
for all samples using a gas chromatograph with electron capture detection at Department of 
Environmental Health, University of Southern Denmark [23]. To avoid problems with PCB 
congeners not assessed or below the detection limit, ΣPCB was calculated as the sum of major 
congeners 138, 153, and 180 multiplied by 2 [33]. o,p′-DDE at 18 months and 5 years, p,p′-DDT 
at 18 months, and o,p′-DDT at 5-years were detected in less than 50% of samples and were 
therefore not further considered. PFHxS, PFOA, PFOS, PFNA, and PFDA concentrations were 
measured using online solid-phase extraction and analyzed using high-pressure liquid 
chromatography with tandem mass spectrometry [34]. The accuracy and reliability of the data 
was ensured by including, in each analytical series, quality control serum samples, calibration 
standards, and reagent and serum blanks. Within-batch and between-batch coefficient of 
variations were better than 3.0% and 5.2% for all analytes. Total mercury analyses in hair and 
blood were performed on a Direct Mercury Analyzer (DMA-80, Milestone Inc, Sorrisole, Italy), 
with imprecision below 4%. All POP results below the limit of detection (LOD) were replaced 
by the LOD divided by √2. 
 
2.4. Statistical analyses 
WBC, Hg, and POP concentrations were all log-transformed (base 2) before they entered the 
models to approximate a normal distribution. One child had very high WBC count (Total=16.4 
x10
9
 cells/L) due to a fever and was consequently removed from the analyses. Due to the large 
number of exposure variables, we used structural equation models (SEM) to assess the covariate-
adjusted associations between prenatal, 18-month, and 5-year exposures and the extended WBC 
counts at 5 years.   
We first conducted an exploratory factor analysis (EFA) without a priori information on 
the structure and correlations in the data, followed by a confirmatory factor analysis (CFA) to 
categorize exposures into a small number of factors, thereby reducing the extent of multiple 
comparisons. For prenatal exposures, this method resulted in three factors explaining 65% of the 
variance. Factor 1 included the 5 PFASs, factor 2 included mercury indicators (i.e., cord blood, 
maternal blood and hair concentrations), and factor 3 included HCB, PCB, p,p′-DDE, o,p′-DDT, 
and p,p′-DDT. For 18-month exposures, the method yielded 2 factors explaining 65% of the 
variance. Factor 1 included the 5 PFASs, whereas factor 2 included HCB, PCB, o,p′-DDT, and 
p,p′-DDE. At 5 years, three factors explained 56% of the variance. Factor 1 included the 5 
PFASs; factor 2 included child hair-Hg and blood-Hg concentrations, whereas factor 3 included 
HCB, PCB, p,p′-DDE, and p,p′-DDT. For the sake of simplicity, factors 1, 2, and 3 will be 
referred to as PFAS, mercury (Hg), and organochlorine (OC) functions, respectively. 
Correlations between the latent functions ranged between 0.07 (for 5-year Hg and OC) and 0.79 
(for 18-month PFAS and OC). Although these correlations show good discriminant validity for 
the constructed factors and are considered reasonable to avoid multicollinearity issues in SEM 
analyses, the small sample size precluded the simultaneous analyses of all the factors in a single 
model. We therefore completed separate SEM analyses linking each latent exposure function 
with each WBC count. For each age, the exposure factors were regressed on the WBC counts, 
while adjusting for covariates. Models for prenatal exposures were adjusted for age at age-5 
examination (months), sex, , parity (no older sibling / 1 or more older siblings), and maternal 
smoking during pregnancy; whereas models for 18-month and 5-year exposures were further 
adjusted for birth weight (g) and duration of breastfeeding (<  or  ≥ 6 months). Missing data for 
breastfeeding (n=2) were compensated by Full Information Maximum Likelihood estimation.  
 
3. Results 
3.1. Descriptive results 
The characteristics of the study population are presented in Table 1. The mean age of children 
was 60 months, with fewer boys than girls (39% vs 61%). Most of the children had an older 
sibling (71%), and 41% were breastfed for 6 months or longer (Table 1). Except for one child 
with a total WBC count below 4 x 10
9
 cells/L, all remaining children were within a normal range 
(4-11 x 10
9
 cells/L) [35]. The total WBC count did not differ in regard to age, sex, parity, 
maternal smoking during pregnancy, birth weight, or breastfeeding duration. 
3.2. Exposures  
Among the PFASs, PFOS showed the highest serum concentrations at all ages, followed by 
PFOA and PFHxS, while PFNA and PFDA occurred in the lowest concentrations (Table 2). 
Between-PFAS correlation coefficients for maternal serum or child at age 18-month and 5-year 
ranged from 0.29 to 0.87 and were higher at 18 months and lower at 5 years. Within-PFAS 
correlation coefficients ranged between 0.28 and 0.79, and were generally higher for the child’s 
18-month and 5-year serum samples and lower between maternal and child at either age (Figure 
1). For mercury exposures, the higher cord blood concentrations were closely correlated with 
those in maternal blood (0.92). Blood- and hair-Hg concentrations were also well correlated on 
each occasion (0.73 for maternal concentrations and 0.89 for child concentrations at age 5). 
Regarding POPs, PCBs showed the highest within correlation coefficient between serum 
concentrations at 18 months and 5 years. PCBs also showed high correlations with the other 
POPs and PFASs at each age (Figure 1). PFAS concentrations at all ages were generally lower in 
mothers with a previous childbirth, whereas POPs at 18 months were lower in children breastfed 
for 6 months or more.  
3.3. WBC counts in relation to exposure levels 
The CFA models exhibited a good to very good fit to the data. All measured exposures showed 
significant and high correlations to their latent functions (Table 3) and therefore appeared as 
appropriate indicators. The variance in observed exposures explained by the latent exposure 
functions ranged between about 50 and 100%.  
SEMs showed an acceptable (age-5 models) to a very good fit to the data. Table 4 shows 
the resulting associations between the latent exposure functions for PFAS, Hg, and OC at each 
age in regard to the WBC counts at 5 years. Higher maternal Hg exposure was consistently 
associated with lower WBC counts. For instance, a one standard deviation (SD) increase in 
maternal Hg concentrations was associated with a 23% SD decrease in lymphocytes (95% 
confidence intervals [CI]: -43, -4%) and a 30% SD decrease in total WBC count (95% CI: -56, -
5%). Maternal OC concentrations were marginally associated with decreases in neutrophil and 
total WBC counts, with a 1-SD increase in maternal OC concentrations associated with a 27% 
SD decrease in total WBC count (95% CI: -57, 4%). Further, a 1-SD increase in 5-years OC 
concentrations was also marginally associated with a 23% SD decrease in total WBC count (95% 
CI: -47, 1%). Finally, higher PFAS concentrations at all ages were associated with higher 
basophil counts (B=28 % SD; 95% CI: -2, 57%, B=34 % SD; 95% CI: 0, 68%, and B=46 % SD; 
95% CI: 13, 79%, respectively for maternal, 18-month, and 5-year PFAS). 
In regard to the specific lymphocyte subpopulations, maternal Hg concentrations were 
significantly associated with decreased CD3
+
 T cells, CD4
+
 cells, CD4-RTE and CD19
+
 B Cells 
concentrations. For instance, a 1-SD increase in maternal Hg concentrations was associated with 
a 23% SD (95% CI: -40, -6%) and a 24% SD (95% CI: -47, -1%) decrease in CD4
+
 T cell and 
19
+
 B cell concentrations, respectively. No associations were observed with 18-month and 5-year 
exposures (Table 5). Attempts to incorporate all exposure information in a single model failed, as 
the fit indices were poor, and signs of multicollinearity issues were observed in the resulting 
estimates, with unstable parameter estimates and negative variances. 
 
4. Discussion 
In this prospective study with age-related mercury and POPs exposure profiles, we found an 
association between prenatal mercury concentrations and depleted total white blood cell counts, 
especially for monocytes, basophils and CD3
+
 T lymphocytes, CD4
+
 T lymphocytes, CD4
+
 
recent thymic emigrants (CD4-RTE), and CD19
+
 B lymphocytes. Further, prenatal and 
concurrent concentrations of organochlorine compounds were marginally associated with 
decreased neutrophil and total WBC counts. Finally, higher 18-month and 5-year PFAS 
concentrations were associated with increased basophil levels in 5-year children.  
Very few studies investigated WBC count in relation to developmental exposure to 
mercury and POPs. Of greatest interest, our study suggests a negative impact on recent thymic 
immigrant cells, as well as on mature lymphocyte subsets. The results are in line with other 
human studies showing decreased lymphocyte [16, 36], and monocyte [37] counts in relation to 
mercury exposures, but contradict a recent cross-sectional study showing a positive correlation 
of the serum-mercury concentration – likely reflecting inorganic mercury exposure – with 
lymphocyte count [15]. In the Faroes, total mercury concentrations in blood and hair primarily 
indicate exposures to methylmercury [38], thus suggesting that different chemical speciations 
may affect the mercury-related toxicity. Mercury-induced cytotoxicity has been demonstrated in 
cells of the immune system, including B cells, T cells, and monocytes [39, 40], and two in vitro 
studies demonstrated that Hg exposure causes mitochondrial dysfunction and enhances the 
apoptosis of neutrophils and mononuclear cells including T cells [41, 42]. However, mercury has 
also been shown to exert immunomodulatory and anti-apoptotic effects in animals [43] and to be 
associated with autoimmune diseases in both animals and humans [44]. Although no clear 
picture has emerged so far, the differences between studies may mainly be attributable to 
differences in concentrations and mercury species, i.e., whether inorganic mercury or 
methylmercury [45].  
Our study also found that OCs tended to have similar effects as mercury, though not 
significantly so. Previous studies have reported similar findings in various settings. Higher PCB 
concentrations were associated with lower neutrophil and lymphocyte percentages, and a lower 
total WBC count [13, 46]. Further, Inuit infants whose mothers had elevated levels of PCBs and 
dioxins in their breast milk had decreased CD4
+
/CD8
+
 T cell ratio at 6 and 12 months of age 
[47]. A joint effect of higher exposures of DDT and PCBs on CD16
+
 NK cells was also observed 
in Japanese infants [22]. Finally, neutrophil counts were inversely related to OC pesticides 
concentrations in the general U.S. population form NHANES 1999-2002 [48].  Similar findings 
have also been reported in animal and in vitro studies [49-52]. The strong correlations between 
PCBs and other OCs exposures observed in this population make it difficult to distinguish 
between effects of specific OC substances. It is also worth mentioning that although we were 
able to collect serum samples and examine OC concentrations at different time points, with 
apparent different associations with neutrophils and total WBC count, it is still challenging to 
state about the exact timing of greatest susceptibility. Given the long half-lives of OCs, the 
serum concentrations at 18 months and 5 years are likely still affected by prenatal and lactational 
transfer from the mother.      
We also observed an association between PFAS exposure and increased basophil count. 
Although the role that basophils play in the immune system has not been thoroughly investigated 
in the past, recent studies revealed their crucial role in various immune responses such as allergy 
and anti-parasitic protective immunity [53]. Importantly, elevated IgE concentrations correlate 
with increased numbers of circulating basophils both in mice and in humans [54], and recent 
evidence from epidemiologic and animal studies suggests that PFASs may be associated with 
allergy and asthma-related outcomes, perhaps as a result of a shift in the host’s immune state 
toward a more TH2-like state [55-59].  
Based on the results from the present study, it is hard to infer any increased risk of 
disease outcome. The observed changes in the WBC counts warrant further investigation, and the 
clinical significance of these changes is unclear at this point. However, these results are 
indicative of immunotoxic and/or immunomodulatory effects of mercury and POPs, and the 
demonstrated effects on the cellular and humoral immune responses might lead to increased 
susceptibility to various infectious diseases or to immune dysfunction with an impaired immune 
tolerance. Interestingly, our findings point to developmental toxicity on the thymus, as 
demonstrated by the lower CD4-RTE concentration, associated with perinatal Hg exposure. One 
may speculate that a compromised thymic function could lead to insufficient T cell helper 
activity for developing B-cell based immunity and in the longer term perhaps also an increased 
risk of autoimmune disease, as may be seen in immune deficiency conditions.  
A major limitation of this study is the small sample size. Although the use of structural 
equation models allowed a reduction of multiple comparisons and a gain in statistical power due 
to the by reduced measurement error, the small sample size did not allow for mutual adjustment 
of the three families of exposures, nor mutual adjustment for pre- and postnatal exposures.  
To our knowledge, this is the first study to investigate associations of both prenatal and 
postnatal exposure to multiple POPs and mercury and children’s WBC counts. Despite the small 
sample size, we were able to adjust for several potentially relevant confounders, and their effect 
on the results was marginal. The potential influence of any unmeasured determinant of WBC 
appears minimal, especially when taking into regard the homogeneity of the Faroese population 
in terms of socio-demographic, lifestyle, and genetic characteristics. Thus, these findings should 
inspire further study of the possible effects of developmental exposure to environmental 
chemicals on children’s immune functions.  
5. Conclusions 
In this study of children from the Faroe Islands, we report an inverse association between 
prenatal mercury and organochlorine exposures and total WBC counts. The finding of 
significantly reduced subpopulations of lymphocytes such as B-lymphocytes, CD4 positive T 
helper cells and CD4 positive recent thymic emigrants suggest an effect of prenatal mercury 
exposure on cellular immunity and a dysregulation of T-cell mediated immunity. Prenatal OC 
exposure was marginally associated with decreases in neutrophil counts, while postnatal PFAS 
concentrations appeared to be associated with increased basophil counts. These observations 
suggest a differential effect of developmental exposures to immunotoxicants on specific 
circulating leukocyte populations in childhood. Importantly, this study provides new evidence of 
the potential immunomodulatory effects of persistent organic pollutants and mercury.   
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TABLES: 
Table 1: Characteristics of the study population (n=55) 
 
Population characteristic Mean (SD) or n (%) 
Age, months 60.1 (0.8) 
Birth weight, grams 3684 (537) 
Maternal age at delivery, years 30.6 (5.7) 
Sex 
 
Boys 22 (40) 
Girls 33 (60) 
Parity 
 
No siblings 16 (29) 
≥ 1 siblings 39 (71) 
Maternal smoking during pregnancy 
 
No 44 (80) 
Yes 11 (20) 
Breastfeeding duration 
 
< 6 months 32 (60) 
≥6 months 21 (40) 
Missing 2 
Differential White blood cells count (10
9
 Cells/L) 
 
Neutrophils 3.13 (1.75) 
Basophils 0.10 (0.13) 
Lymphocytes 2.57 (0.84) 
CD3 2.00 (0.62) 
CD4 1.11 (0.40) 
CD8 0.75 (0.26) 
CD4-RTE 0.55 (0.24) 
B Cells 0.56 (0.24) 
NK Cells 0.16 (0.07) 
Monocytes 0.43 (0.15) 
Eosinophils 0.31 (0.25) 
Total WBC 6.54 (2.12) 
 
  
Table 2: Descriptive statistics of maternal and child’s exposures (µg/L) 
 
Maternal exposures (n=55) 18-month exposures (n=41) 5-year exposures (n=53) 
 
# < 
LOD 
GM GSE Range 
# < 
LOD 
GM GSE Range 
# < 
LOD 
GM GSE Range 
PFOA 0 1.470 0.100 0.46 - 4.13 0 3.580 0.391 0.85 - 22.52 0 2.596 0.128 1.44 - 13.34 
PFNA 0 0.789 0.056 0.30 - 4.35 0 1.244 0.135 0.23 - 7.10 0 1.358 0.095 0.38 - 5.75 
PFDA 0 0.298 0.020 0.12 - 0.91 0 0.347 0.033 0.1 - 3.29 0 0.357 0.024 0.11 - 1.72 
PFHxS 1 0.240 0.022 <LOD - 0.86 3 0.247 0.045 <LOD - 3.77 0 0.372 0.032 0.14 - 3.25 
PFOS 0 9.075 0.495 3.67 -19.31 0 8.252 0.761 1.95 - 28.30 0 5.058 0.261 2.17 - 11.72 
∑PCB 0 0.470 0.051 0.07 - 1.90 0 0.734 0.108 0.07 - 3.07 0 0.465 0.067 0.02 - 2.60 
HCB 0 0.018 0.001 0.005 - 0.08 6 0.032 0.003 <LOD - 0.11 0 0.025 0.002 0.008 - 0.08 
Blood-Hg 0 3.066 0.255 0.53 - 19.96 - - - - 0 2.328 0.242 0.21 - 9.97 
Hair-Hg 0 0.748 0.073 0.14 - 3.88 - - - - 0 0.611 0.084 0.02 - 5.76 
Cord blood-Hg 0 4.649 0.371 0.77 - 21.06 - - - - - - - - 
o,p’-DDE 15 n/a n/a <LOD - 0.02 38 n/a n/a <LOD -0.11 47 n/a n/a <LOD -0.001 
p,p’-DDE 0 0.142 0.020 0.02 - 1.38 3 0.271 0.053 <LOD - 1.95 0 0.229 0.032 0.02 - 1.78 
o,p’-DDT 2 0.009 0.001 <LOD -0.14 11 0.033 0.004 <LOD - 0.23 29 n/a n/a <LOD - 0.003 
p,p’-DDT 2 0.007 0.001 <LOD - 0.09 31 n/a n/a <LOD - 0.09 3 0.001 0.000 <LOD - 0.008 
  
  
Table 3. Results of the confirmatory factor analysis for prenatal, 18-month, and 5-year 
exposures. 
  Factors Indicators Loading SE p-value 
Standardized 
estimate 
Prenatal 
PFAS 
PFOA 1.00 0.00 NA 0.65 
PFNA 1.22 0.25 <0.001 0.78 
PFDA 1.43 0.30 <0.001 0.94 
PFOS 1.04 0.20 <0.001 0.83 
PFHxS 1.29 0.38 0.001 0.62 
OC 
HCB 1.00 0.00 NA 0.92 
PCB 1.34 0.17 <0.001 0.84 
p,p′-DDE 1.80 0.19 <0.001 0.87 
o,p′-DDT 1.44 0.25 <0.001 0.65 
p,p′-DDT 1.33 0.20 <0.001 0.7 
Hg 
hair Hg 1.00 0.00 NA 0.87 
blood Hg 0.91 0.13 <0.001 0.91 
CB-Hg 0.95 0.11 <0.001 0.99 
18 
months 
PFAS 
PFOA 1.00 0.00 NA 0.89 
PFNA 1.03 0.10 <0.001 0.92 
PFDA 0.88 0.11 <0.001 0.9 
PFOS 0.86 0.12 <0.001 0.9 
PFHxS 1.56 0.23 <0.001 0.82 
OC 
HCB 1.00 0.00 NA 0.94 
PCB 1.83 0.28 <0.001 0.99 
p,p′-DDE 1.62 0.61 0.008 0.65 
o,p′-DDT 1.27 0.11 <0.001 0.65 
5 years 
PFAS 
PFOA 1.00 0.00 NA 0.54 
PFNA 1.74 0.48 <0.001 0.67 
PFDA 1.32 0.39 0.001 0.53 
PFOS 1.59 0.52 0.002 0.85 
PFHxS 1.95 0.52 <0.001 0.62 
OC 
HCB 1.00 0.00 NA 0.97 
PCB 1.85 0.33 <0.001 0.84 
p,p′-DDE 1.80 0.27 <0.001 0.83 
p,p′-DDT 1.05 0.22 <0.001 0.5 
Hg 
hair Hg 1.00 0.00 NA 0.89 
blood Hg 0.84 0.35 0.02 1 
 
 
Table 4. Associations between PFAS, Hg, and POPs exposure and WBC concentrations at 5 
years of age. Estimate is expressed as the change in leukocytes SD associated with a one SD change in the 
exposure.  
 
  
Maternal exposures 18-month exposures 5-year exposures 
Leukocytes Exposures 
Std 
Estimate 
Lower 
CI 
Upper 
CI 
p-
value 
Std 
Estimate 
Lower 
CI 
Upper 
CI 
p-
value 
Std 
Estimate 
Lower 
CI 
Upper 
CI 
p-
value 
Neutrophils 
PFAS -0.14 -0.44 0.17 0.37 0.09 -0.19 0.37 0.53 -0.06 -0.44 0.31 0.73 
Hg -0.26 -0.54 0.02 0.07 - - - - 0.13 -0.05 0.30 0.16 
OC -0.30 -0.64 0.03 0.07 -0.14 -0.48 0.20 0.41 -0.21 -0.43 0.01 0.07 
Basophils 
PFAS 0.28 -0.02 0.57 0.07 0.34 0.00 0.68 0.05 0.46 0.13 0.79 0.01 
Hg -0.09 -0.32 0.14 0.46 - - - - -0.17 -0.59 0.24 0.41 
OC 0.21 -0.08 0.50 0.15 0.25 -0.13 0.62 0.19 0.18 -0.24 0.59 0.40 
Eosinophils 
PFAS -0.07 -0.32 0.17 0.56 0.14 -0.20 0.48 0.43 -0.06 -0.38 0.27 0.73 
Hg -0.14 -0.48 0.19 0.41 - - - - -0.11 -0.35 0.13 0.38 
OC -0.11 -0.39 0.17 0.45 0.16 -0.17 0.48 0.35 -0.08 -0.31 0.15 0.48 
Lymphocytes 
PFAS -0.04 -0.30 0.22 0.78 0.16 -0.13 0.45 0.27 -0.11 -0.36 0.14 0.39 
Hg -0.23 -0.43 -0.04 0.02 - - - - -0.01 -0.20 0.18 0.90 
OC -0.10 -0.35 0.14 0.41 0.20 -0.11 0.51 0.20 -0.18 -0.46 0.10 0.22 
Monocytes 
PFAS -0.10 -0.38 0.19 0.51 0.16 -0.12 0.43 0.26 0.05 -0.34 0.44 0.80 
Hg -0.23 -0.46 0.00 0.05 - - - - -0.07 -0.30 0.16 0.56 
OC -0.17 -0.46 0.11 0.23 -0.08 -0.37 0.21 0.59 -0.06 -0.28 0.15 0.56 
Total WBC 
PFAS -0.11 -0.40 0.19 0.47 0.15 -0.13 0.44 0.28 -0.06 -0.38 0.25 0.70 
Hg -0.30 -0.56 -0.05 0.02 - - - - 0.06 -0.11 0.23 0.46 
OC -0.27 -0.57 0.04 0.08 0.00 -0.34 0.34 1.00 -0.23 -0.47 0.01 0.06 
Table 5. Associations between PFAS, Hg, and POP exposures and specific lymphocyte counts at 
5 years of age. Estimates are expressed as the relative change in regard to the leukocyte SD 
associated with a one SD increase in the exposure.  
  
Maternal exposures 18-month exposures 5-year exposures 
Lymphocytes Exposures 
Std 
Estimate 
Lower 
CI 
Upper 
CI 
p-
value 
Std 
Estimate 
Lower 
CI 
Upper 
CI 
p-
value 
Std 
Estimate 
Lower 
CI 
Upper 
CI 
p-
value 
CD3 T cells 
PFAS -0.12 -0.36 0.13 0.36 0.09 -0.31 0.49 0.66 -0.15 -0.40 0.10 0.24 
Hg -0.22 -0.41 -0.04 0.02 - - - - 0.00 -0.08 0.09 0.95 
OC -0.11 -0.34 0.12 0.37 0.13 -0.20 0.47 0.42 -0.19 -0.51 0.14 0.26 
CD4 T cells 
PFAS -0.12 -0.37 0.13 0.35 0.07 -0.29 0.43 0.71 -0.18 -0.44 0.07 0.16 
Hg -0.23 -0.40 -0.06 0.01 - - - - 0.04 -0.16 0.24 0.72 
OC -0.10 -0.33 0.13 0.41 0.12 -0.20 0.44 0.46 -0.22 -0.56 0.11 0.19 
CD8 T cells 
PFAS -0.12 -0.36 0.12 0.32 0.16 -0.27 0.59 0.46 -0.08 -0.33 0.17 0.53 
Hg -0.16 -0.38 0.06 0.15 - - - - -0.05 -0.26 0.17 0.68 
OC -0.13 -0.37 0.10 0.27 0.17 -0.20 0.53 0.37 -0.09 -0.40 0.21 0.55 
CD4-RTE 
PFAS -0.05 -0.32 0.22 0.70 0.23 -0.08 0.53 0.14 -0.12 -0.35 0.11 0.31 
Hg -0.26 -0.45 -0.08 0.01 - - - - 0.00 -0.07 0.08 0.91 
OC -0.10 -0.34 0.14 0.41 0.20 -0.28 0.69 0.42 -0.05 -0.40 0.29 0.76 
NK cells 
PFAS -0.12 -0.41 0.18 0.43 -0.20 -0.50 0.09 0.18 0.16 -0.16 0.48 0.33 
Hg -0.11 -0.33 0.11 0.32 - - - - -0.02 -0.10 0.06 0.63 
OC 0.11 -0.13 0.35 0.38 -0.22 -0.66 0.22 0.33 -0.13 -0.40 0.15 0.36 
B cells 
PFAS -0.06 -0.33 0.21 0.65 0.19 -0.08 0.47 0.17 -0.12 -0.42 0.17 0.41 
Hg -0.24 -0.47 -0.01 0.04 - - - - 0.05 -0.16 0.26 0.62 
OC -0.10 -0.38 0.17 0.46 0.09 -0.22 0.40 0.59 -0.14 -0.42 0.14 0.33 
 
  
FIGURES 
 
Figure 1: Correlation heat map and hierarchical clustering of maternal, 18-month, and 5-year 
POPs and Hg exposures. Red represents positive correlations whereas blue represents negative ones. The 
intensity of the color is a function of the correlation.  
 
 
 
 
